{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:59:56Z","timestamp":1770814796735,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T00:00:00Z","timestamp":1530835200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1038\/s41433-018-0160-x","type":"journal-article","created":{"date-parts":[[2018,7,6]],"date-time":"2018-07-06T09:03:01Z","timestamp":1530867781000},"page":"1697-1702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Fundoscopy screening for intraocular candida in patients with positive blood cultures\u2014is it justified?"],"prefix":"10.1038","volume":"32","author":[{"given":"Mariam","family":"El-Abiary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7984-0958","authenticated-orcid":false,"given":"David","family":"Lockington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,6]]},"reference":[{"key":"160_CR1","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1128\/CMR.00029-06","volume":"20","author":"MA Pfaller","year":"2007","unstructured":"Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133\u201363.","journal-title":"Clin Microbiol Rev"},{"key":"160_CR2","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1099\/jmm.0.47239-0","volume":"56","author":"FC Odds","year":"2007","unstructured":"Odds FC, Hanson MF, Davidson AD, Jacobson MD. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol. 2007;56:1066\u201375.","journal-title":"J Med Microbiol"},{"key":"160_CR3","doi-asserted-by":"crossref","unstructured":"Vazquez JA, Sobel JD: Candidiasis. In: Clinical Mycology. Dismukes WE, Pappas PG, Sobel JD. Oxford University Press, Oxford, UK; 2003. p. 143\u2013187.","DOI":"10.1093\/oso\/9780195148091.003.0011"},{"key":"160_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2147\/TCRM.S40160","volume":"10","author":"N Yapar","year":"2014","unstructured":"Yapar N. Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag. 2014;10:95\u2013105.","journal-title":"Ther Clin Risk Manag"},{"key":"160_CR5","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1001\/archinte.1989.00390100056014","volume":"149","author":"R Brooks","year":"1989","unstructured":"Brooks R. Prospective study of candida endophthalmitis in hospitalised patients with candidaemia. Arch Intern Med. 1989;149:2226\u20138.","journal-title":"Arch Intern Med"},{"key":"160_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S0161-6420(82)34722-3","volume":"89","author":"DW Parke","year":"1982","unstructured":"Parke DW, Jones DB, Gentry LO. Endogenous endophthalmitis among patients with candidaemia. Ophthalmology. 1982;89:789\u201396.","journal-title":"Ophthalmology"},{"key":"160_CR7","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0161-6420(94)31175-4","volume":"101","author":"SP Donahue","year":"1994","unstructured":"Donahue SP, Greven CM, Zuravleff JJ, Eller AW, Nguyen MH, Peacock JE Jr et al. Intraocular candidiasis in patients with candidemia: clinical implications derived from a prospective multicenter study. Ophthalmology . 1994;101:1302\u20131209.","journal-title":"Ophthalmology"},{"key":"160_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, et al. Infectious Diseases Scoety of America: clinical and practical guidelines for the management of candidiasis. Clin Inf Dis. 2016;62:1\u201350.","journal-title":"Clin Inf Dis"},{"key":"160_CR9","unstructured":"Fungal Infection Study Group. ESCMID Guideline for the Diagnosis and Management of Candida Diseases 2012. European Society of Clinical Microbiology and Infectious Diseases; 2012."},{"key":"160_CR10","unstructured":"Lightman SMH Eye Care in ICU. Clinical Guidance. Royal College of Ophthalmologists and Intensive Care Society; 2017."},{"key":"160_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.ijid.2012.12.014","volume":"17","author":"MJ Vinikoor","year":"2014","unstructured":"Vinikoor MJ, Zoghby J, Cohen KL, Tucker JD. Do all candidaemic patients need an ophthalmic examination? Int J Infect Dis. 2014;17:146\u20138.","journal-title":"Int J Infect Dis"},{"key":"160_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/00005792-197401000-00002","volume":"53","author":"JE Edwards Jr","year":"1974","unstructured":"Edwards JE Jr, Foos RY, Montgomerie JZ, Guze LB. Ocular manifestations of candida septicaemia: review of 76 cases of haemtogenous candida endophthalmitis. Medicine. 1974;53:47\u201375.","journal-title":"Medicine"},{"key":"160_CR13","first-page":"67","volume":"100","author":"SS Feman","year":"2002","unstructured":"Feman SS, Nichols JC, Chung SM, Theobald TA. Endopthalmitis in patients with disseminated fungal disease. Trans Am Ophthalmol Soc. 2002;100:67\u201372.","journal-title":"Trans Am Ophthalmol Soc"},{"key":"160_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/eye.2000.7","volume":"14","author":"R Krishna","year":"2000","unstructured":"Krishna R, Amuh D, Lowder CY, Gordon AM, Adal KA, Hall G. Should all patients with candidaemia have an ophthalmic examination to rule out ocular candidiasis? Eye. 2000;14:30\u201334.","journal-title":"Eye"},{"key":"160_CR15","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.ophtha.2011.01.038","volume":"118","author":"CC Dozier","year":"2011","unstructured":"Dozier CC, Tarantola RM, Jiramongkolchai K, Donahue SP. Fungal eye disease at a tertiary care centre: the utility of routine inpatient consultation. Ophthalmology. 2011;118:1671\u20136.","journal-title":"Ophthalmology"},{"key":"160_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/bjo.2007.133405","volume":"92","author":"CP Shah","year":"2008","unstructured":"Shah CP, McKey J, Spirn MJ, Maguire J. Ocular Candidiasis: a review. Br J Ophthalmol. 2008;92:466\u20138.","journal-title":"Br J Ophthalmol"},{"key":"160_CR17","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1592\/phco.27.12.1711","volume":"27","author":"FA Khan","year":"2007","unstructured":"Khan FA, Slain D, Khakoo RA. Candida endophthalmitis: focus on current and future antifungal treatment options. Pharmacotherapy. 2007;27:1711\u201321.","journal-title":"Pharmacotherapy"},{"key":"160_CR18","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1086\/496922","volume":"41","author":"TE Zaoutis","year":"2005","unstructured":"Zaoutis TE, Argon J, Chu J, Berlin J, Walsh T, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis. 2005;41:1232\u20139.","journal-title":"Clin Infect Dis"},{"key":"160_CR19","first-page":"1853","volume":"9","author":"E Geramovych","year":"2015","unstructured":"Geramovych E,Conduff JH,Barich PS,Leffler CT,Brar VS, Prevalence and factors predictive of intraocular fungal infection in patients with fungaemia at an Urban Tertiary Care Center. Clin Ophthalmol. 2015;9:1853\u20138.","journal-title":"Clin Ophthalmol"},{"key":"160_CR20","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ajo.2015.07.033","volume":"160","author":"MK Adam","year":"2015","unstructured":"Adam MK, Vahedi S, Nichols MM, Fintelmann RE, Keenan JD, Garg SJ et al. Inpatient ophthalmology consultation for fungaemia: prevalence of ocular involvement and necessity of fundoscopic screening. Am J Ophthal. 2015;160:1078\u201383.","journal-title":"Am J Ophthal"},{"key":"160_CR21","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/j.ophtha.2014.06.042","volume":"121","author":"DH Ghodasra","year":"2014","unstructured":"Ghodasra DH, Eftekhari K, Shah AR, Vanderbeek. Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting. Ophthalmology. 2014;121:2334\u20138.","journal-title":"Ophthalmology"},{"key":"160_CR22","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/IAE.0000000000000919","volume":"36","author":"YM Paulus","year":"2016","unstructured":"Paulus YM, Cheng S, Karth PA, Leng T. Prospective trial of endogenous endophthalmitis and chorioretinitis rates, clinical course and outcomes in patients with fungaemia. Retina. 2016;36:1357\u201363.","journal-title":"Retina"},{"key":"160_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/CMR.00046-13","volume":"27","author":"T Felton","year":"2014","unstructured":"Felton T, Troke PF, Hope WW. tissue penetration of antifungal agents. Clin Microbiol Rev. 2014;27:68\u201388.","journal-title":"Clin Microbiol Rev"},{"key":"160_CR24","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/cid\/ciq204","volume":"52","author":"J Riddell","year":"2011","unstructured":"Riddell J, Comer GM, Kauffmann CA. Treatment of endogenous fungal endophthalmitis: focus on new antifungal agents. Clin Infect Dis. 2011;52:648\u201353.","journal-title":"Clin Infect Dis"},{"key":"160_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1128\/AAC.31.1.6","volume":"31","author":"DV Savani","year":"1987","unstructured":"Savani DV, Perfect JR, Cobo LM, Durack DT. Penetration of new azole compounds into the eye and efficacy in experimental candida endophthalmitis. Antimicrob Agents Chemother. 1987;31:6\u201310.","journal-title":"Antimicrob Agents Chemother"},{"key":"160_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/archopht.122.1.42","volume":"122","author":"SM Hariprasad","year":"2004","unstructured":"Hariprasad SM, Mieler WF, Holz ER. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004;122:42\u201347.","journal-title":"Arch Ophthalmol"},{"key":"160_CR27","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/sj.eye.6701427","volume":"19","author":"D Varma","year":"2005","unstructured":"Varma D, Thaker HR, Moss PJ, Wedgwood K, Innes JR. Use of voriconazole in Candida retinitis. Eye. 2005;19:485\u20137.","journal-title":"Eye"},{"key":"160_CR28","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/bjo.2007.136515","volume":"92","author":"SM Hariprasad","year":"2008","unstructured":"Hariprasad SM, Mieler WF, Lin TK, Sponsel WE, Graybill JR. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008;92:871\u20138.","journal-title":"Br J Ophthalmol"},{"key":"160_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3341\/kjo.2005.19.1.73","volume":"19","author":"GJ Jang","year":"2005","unstructured":"Jang GJ, Kim KS, Shin WS, Lee WK. Treatment of candida chorioretinitis with voriconazole. Korean J Ophthalmol. 2005;19:73\u201376.","journal-title":"Korean J Ophthalmol"},{"key":"160_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2004.08.077","volume":"139","author":"SM Breit","year":"2005","unstructured":"Breit SM, Hariprasad SM, Mieler WF, Shah GK, Mills MD, Grand MG. Management of endogenous fungal endophthalmitis with voriconazole and caspofungin. Am J Ophthalmol. 2005;139:135\u201340.","journal-title":"Am J Ophthalmol"},{"key":"160_CR31","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1086\/514972","volume":"27","author":"C Martinez-Vazquez","year":"1998","unstructured":"Martinez-Vazquez C, Fernandez-Ulloa J, Bordon J. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis. 1998;27:1130\u20133.","journal-title":"Clin Infect Dis"},{"key":"160_CR32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/00006982-200509000-00010","volume":"25","author":"YQ Zhang","year":"2005","unstructured":"Zhang YQ, Wang WJ. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina. 2005;25:746\u201350.","journal-title":"Retina"},{"key":"160_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF02160341","volume":"225","author":"T Barrie","year":"1987","unstructured":"Barrie T. The place of elective vitrectomy in the management of patients with candida endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 1987;225:107\u201313.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"160_CR34","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/0002-9394(76)90005-2","volume":"82","author":"RC Snip","year":"1976","unstructured":"Snip RC, Michels G. Pars plana vitrectomy in the management og endogenous endophthalmitis. Am J Ophthalmol. 1976;82:699\u2013704.","journal-title":"Am J Ophthalmol"},{"key":"160_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/cid\/cir355","volume":"53","author":"AML Oude Lashof","year":"2011","unstructured":"Oude Lashof AML, Rothova A, Sobel J, Ruhnke M, Pappas PG, Viscoli C et al. Ocular manifestations of candidaemia. Clin Infect Dis. 2011;53:262\u20138.","journal-title":"Clin Infect Dis"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0160-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0160-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0160-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:03:14Z","timestamp":1720396994000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-018-0160-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,6]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1038\/s41433-018-0160-x","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,6]]},"assertion":[{"value":"8 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}